All Stories

  1. Persistence of Post-Acute COVID-19 Sequelae (PASC) symptoms in healthcare workers four years after ancestral SARS-CoV-2 infection: a prospective multicentre cohort
  2. Decision-making after joint aspiration: C-reactive protein and synovial white blood cell count as laboratory indicators for surgical joint lavage in pediatric septic arthritis
  3. Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss study
  4. Parvovirus-B19-Infektionen
  5. Sexuell übertragbare Infektionen
  6. Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis
  7. Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study
  8. Breastfeeding with HIV in a high-income setting: equipoise and beyond – time to question the zero-risk policy
  9. Impact of SARS-CoV-2 Pandemic on Pediatric Inpatients with Invasive Group A Streptococcal Infections (iGAS): Results of a National Survey
  10. Untargeted Metabolite Profile Associations With Body Mass Index, Waist–Hip Ratio, and Antiretroviral Therapy in >1300 People With HIV: The Swiss HIV Cohort Study
  11. Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers
  12. Leukocyte count and new‐onset diabetes mellitus in people with HIV: A longitudinal study
  13. Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshop
  14. Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009–2022
  15. Diet Diversity and Adherence to a Mediterranean Diet Pattern in Pregnancy Is Protective Against the Development of Early-Childhood Atopic Dermatitis
  16. Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study
  17. Types of Myocardial Infarction in People With HIV in Switzerland
  18. Dynamic of Pediatric Invasive Bacterial Infections in Switzerland: A 2017–2024 Time-series Analysis of National Data
  19. Outcomes After Prenatal Exposure to Raltegravir-Containing Antiretroviral Therapy: A Multicohort European Study
  20. Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022
  21. Evaluation of self-collected dried blood spots for detection of SARS-CoV-2 nucleocapsid antibodies shows low sensitivity
  22. Fluorescent Probe for the pH-Independent Rapid and Sensitive Direct Detection of Urease-Producing Bacteria
  23. Burden of post–acute COVID-19 sequelae in healthcare workers and its course over a 30-month period–results from a prospective multicentre cohort
  24. Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study
  25. Syphilis in pregnant women and congenital syphilis from 2012 to 2021 in Switzerland: a multicentre, retrospective study
  26. HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey
  27. Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)
  28. Evaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
  29. Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis
  30. SARS‐CoV‐2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study
  31. Clinical Characteristics and Management of Children and Adolescents Hospitalized With Pyomyositis
  32. Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study
  33. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study
  34. Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter
  35. Impact of shift work and other work-related factors on anti-SARS-CoV-2 spike-protein serum concentrations in healthcare workers after primary mRNA vaccination – a retrospective cohort study
  36. S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5
  37. Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort
  38. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients
  39. Organ Dysfunction in Children With Blood Culture-Proven Sepsis: Comparative Performance of Four Scores in a National Cohort Study
  40. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study
  41. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies
  42. SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study
  43. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study
  44. Development of hybrid immunity during a period of high incidence of Omicron infections
  45. Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study
  46. Sensitivity of ICD coding for sepsis in children—a population-based study
  47. Clinical symptoms of SARS‐CoV‐2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination—A prospective multicentre cohort of health professionals (SURPRISE study)
  48. Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study
  49. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study
  50. Reply to Zeng and Zhou
  51. Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV
  52. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021): a longitudinal study in Switzerland
  53. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
  54. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
  55. The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model
  56. Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry
  57. Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland – baseline findings from the first two years of the KIDS-STEP trial
  58. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
  59. Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland
  60. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
  61. Implementation of an electronic, secure, web-based application to support routine hand hygiene observation with immediate direct feedback and anonymized benchmarking
  62. Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment
  63. Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
  64. Swiss recommendations on perioperative antimicrobial prophylaxis in children
  65. Lifestyle Behaviours of Children and Adolescents During the First Two Waves of the COVID-19 Pandemic in Switzerland and Their Relation to Well-Being: An Observational Study
  66. Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland
  67. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
  68. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
  69. Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type
  70. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas
  71. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand
  72. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
  73. The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
  74. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort
  75. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
  76. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
  77. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
  78. SwissPedData: Standardising hospital records for the benefit of paediatric research
  79. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
  80. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
  81. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
  82. Children living with HIV in Europe: do migrants have worse treatment outcomes?
  83. Interseasonal RSV infections in Switzerland – rapid establishment of a clinician-led national reporting system (RSV EpiCH)
  84. Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)
  85. Clinical data for paediatric research: the Swiss approach
  86. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study
  87. Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
  88. Maternal outcomes and risk factors for COVID-19 severity among pregnant women
  89. Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
  90. Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
  91. The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review
  92. The influence of human genetic variation on Epstein–Barr virus sequence diversity
  93. Leptospirosis Followed by Kawasaki-Like Disease: Case Report From an Adult Swiss Patient and Review of the Literature
  94. Can antibody tests accurately detect prior SARS-CoV-2 infection?
  95. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
  96. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland
  97. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study
  98. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
  99. Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study
  100. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
  101. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
  102. Swiss consensus recommendations on urinary tract infections in children
  103. Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study
  104. Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine
  105. Whole-exome sequencing for the identification of rare variants in primary immunodeficiency genes in children with sepsis - a prospective population-based cohort study
  106. Temporal Course of SARS‐CoV‐2 Antibody Positivity in Patients with COVID‐19 following the First Clinical Presentation
  107. SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1–Nrf2
  108. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand
  109. Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
  110. The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
  111. Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study
  112. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review
  113. Birth Defects Following Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy
  114. Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales
  115. Time-to-Positivity of Blood Cultures in Children With Sepsis
  116. Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?
  117. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
  118. Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study
  119. Hand hygiene adherence in relation to influenza season during 6 consecutive years
  120. Akutes rheumatisches Fieber
  121. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study
  122. Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study
  123. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
  124. OUP accepted manuscript
  125. Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland
  126. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland
  127. Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy
  128. Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland
  129. Syphilis: Diagnostik und Behandlung
  130. Primary cutaneous aspergillosis in a preterm neonate
  131. Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung
  132. Mikrobiom – die Entdeckung eines Organs
  133. Postexpositionelle Prophylaxe (PEP) von HIV ausserhalb des Medizinalbereichs
  134. Determinants of Hepatitis A Vaccine Immunity in a Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland
  135. To Say or Not to Say: A Qualitative Study on the Disclosure of Their Condition by Human Immunodeficiency Virus–Positive Adolescents
  136. Sudden infant death syndrome in infants born to HIV-infected and opiate-using mothers
  137. Akutes Fieber beim Kleinkind
  138. Statin-induced immunomodulatory effects on human T cells in vivo
  139. Gynecomastia and potent antiretroviral therapy
  140. Ritonavir boosted indinavir treatment as a simplified maintenance ‘mono'-therapy for HIV infection
  141. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl
  142. Sensitization to Human Immunodeficiency Virus in Seronegative Exposed Partners